Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 65043

AbstractMaterial and MethodsResultsDiscussionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2012 | Month : September | Volume : 6 | Issue : 7 | Page : 1174 - 1177 Full Version

Convulsive Status Epilepticus- A Clinical Radiological and Outcome Study from Uttar Pradesh, India


Published: September 1, 2012 | DOI: https://doi.org/10.7860/JCDR/2012/.2432
Malini Kulshrestha, Manmohan Krishna Pandey, Ramesh Kumar Patial

1. Assistant Professor, Department of Medicine, 2. Assistant Professor, Department of Medicine, 3. Professor and Head of Department of Medicine, Rohilkhand Medical College & Hospital, Bareilly (U.P.)-243006 , India.

Correspondence Address :
Dr. Malini Kulshrestha,
Assistant Professor, Department of, Medicine
Rohilkhand Medical College & Hospital,
Bareilly (U.P.)-243006, India.
Phone : 09897112341
E-mail: malinik@gmail.com

Abstract

Context:
Status Epilepticus (SE) is a neurological emergency which is associated with heterogeneous aetiopathologies, which vary with time and cultural and environmental factors.
Aim:
To analyze the current trends of the clinical profile of SE in our region and to study the predictors of the response of Anti - Epileptic Drugs (AED).
Settings and Design:
A prospective, cross sectional study was done on 50 patients who presented with SE with a duration of 5 minutes or more, at a medical college which is located in the state of Uttar Pradesh, India.
Materials and Methods:
A detailed history was taken and neurological examinations and baseline investigations were done in all the patients. Cerebrospinal Fluid (CSF) analysis was done wherever it was indicated and CT scan / MRI of the brain was carried out in a majority of the patients. The response to the first line of drugs and the outcome were noted and they were correlated with the aetiology and the duration of SE. Results: The mean age of the patients who presented with SE was 29.94±1.76 years and their ages ranged from 12 to 75 years. The duration between the onset of SE and the hospital treatment averaged at 23.56 ± 3.16 hours, ranging from 1hr to 90 hrs. Twenty six percent of the patients were presented within ≤ 6 hrs. The atiology was acute symptomatic in 52% of the cases and the commonest cause was Central Nervous System (CNS) infections. 22% cases of SE were established as epileptic cases with a poor drug compliance. CT/MRI was found to be normal in 44.1 % patients when it was done on 49 patients, wherein ring enhancing lesions were the commonest abnormality which was found. CSF analysis was done in seven patients who presented as meningo-encephalitis. 88% patients had responded to the first line drugs. Two deaths out of 3 corresponded to the acute symptomatic group.
Conclusions:
SE had a variable prognosis depending on its duration and the aetiology of the seizure.

Keywords

Acute symptomatic SE, Duration of SE, Neurocysticercosis, Status epilepticus

Introduction
Status Epilepticus (SE) is a neurological emergency which may cause significant morbidity and mortality in the patients, if it is not treated effectively in time. The aetiology varies among the different age groups. Its incidence has a U-shaped curve, which is more common at the extremes of the ages (1). The aetiopathologies may be heterogeneous, which may vary with time and cultural and environmental factors (1). A periodic analysis is therefore necessary to know the current trends of the aetiology of SE. Due to the dearth of information on this aspect, this study was conducted to generate the baseline data which pertained to the aetiologies and the clinical profile of SE in our region.

Material and Methods

The present study was conducted at a medical college which is located in the state of Uttar Pradesh, India, after seeking the approval of the ethical committee of the college. All the patients of convulsive status epilepticus were included in the study after taking an informed consent from them. SE was defined as (a) a continuous seizure of more than 5 minutes duration or (b) two or more discrete seizures of five minutes duration between which there was an incomplete recovery of consciousness (2). These patients were subjected to a detailed recording of their collateral history, neurological examinations and routine investigations which included a haemogram and a metabolic profile assessment which included O riginal Article I nternal Medicine Sectionthat of serum calcium and magnesium. CT scan / MRI and lumbar puncture were done whenever they were indicated after controlling the seizures. All the patients were treated with intravenous diazepam and phenytoin according to the protocol- intravenous diazepam (0.15 mg/kg), followed by the intravenous loading of phenytoin (20 mg/kg) as the first-line drug treatment. If the seizure did not stop within 30 minutes of the starting of the loading dose of phenytoin, the patients were given additional intravenous phenytoin (5 mg/kg). The second line drugs were given when no response was observed with the above drugs in the first hour. The second line drugs were- an intravenous loading dose of valproate (25-30 mg/kg) or phenobarbitone (20 mg/kg) as the loading dose, followed by a maintenance drip (60 mg/min) till the seizures were under control or till one hour, whichever was earlier. If the seizures could still not be controlled after one hour (refractory seizures), thiopentone (10-20 mg/kg) as a loading dose, followed by an infusion (0.5-1.0 mg/kg/hr) was given along with mechanical ventilatory support. In addition, the patients received appropriate treatment for the underlying disease. The aetiology of SE was classified as (1) acute symptomatic SE which occurred in patients with an acute medical or neurological illness; (2) remote symptomatic SE which owed to the conditions, resulting in a static encephalopathy or an antecedent insult such as stroke, head injury scars or calcifications (3) cryptogenic: SE which owed to the conditions which were presumed to be symptomatic,whose cause was unclear, and (4) established epilepsy (with or without non-compliance) (3). The response to the Anti Epileptic Drug (AED) treatment was defined as the clinical cessation of the epileptic status for at least 12 hours after the completion of the drug administration. Those patients who failed to respond to the initial diazepam and the loading dose of phenytoin were defined as non responders. Variables like the duration of SE and the aetiologies were noted for the group of non responders also.

Results

This study was conducted during October 2011 to March 2012. 50 patients with convulsive SE were admitted to the emergency ward of the medicine department, whose mean age was 29.94 ± 1.76 years and whose ages ranged from 12 to75 years. 11 patients were in the younger age group i.e. 11-20 years, whereas a majority of the patients (28) fell into the young adult group i.e., 21-40 years (Table/Fig 1). The male to female ratio was found to be equal i.e., 1:1.1. The SE was of the generalized tonic–clonic type from the onset in thirty four patients and and it had a focal onset with secondary generalization in 16 patients. The mean duration of SE was 23.56 ± 3.16 hours, which ranged from 1 to 90 hours. Out of 13 patients who presented within ≤ 6 hours, only 3 patients were presented within the first hour of the onset of the epileptic status. All the patients with an SE duration of ≤ 6 hours (n=13) were residents of the city where the institute was located. (Table/Fig 1). The aetiology was acute symptomatic in 52 % patients, it was remote symptomatic in 2 % patients and it was cryptogenic in 24 % patients. 11 of the SE patients were identified as established epileptics with a poor drug compliance. Amongst these, (5) patients missed the AED treatment due to forgetfulness, (4) had financial limitations in continuing the drugs and 2 stopped the medicines due to ignorance. In the acute symptomatic SE patients, CNS infections were the commonest aetiology (n=19 patients). Neurocysticercosis (NCC) was found to be the most frequent infection, followed by meningo-encephalitis (Table/Fig 2). In the vascular aetiology of symptomatic SE, non haemorrhagic- ischaemic stroke was found to be the commonest cause (n=5). One of the patients in this subgroup had associated rheumatic 2heart disease with mitral stenosis and mitral atrial fibrillation and a thrombo embolic infarct. 2 patients had SE due to metabolic disorders like hyperglycaemia and hyponatraemia. Depending upon the affordability, MRI and CT of the brain could be done in 18 and 31 patients respectively. One patient attendant did not allow any of these radiological investigations due to the fact that this patient had established epilepsy and as he/she had presented with an abrupt AED withdrawal. CT / MRI was unremarkable in 23 (44.1 %) patients. A ring enhancing lesion was seen in 10 patients, among which 6 had solitary cysticercus granuloma, while 4 had multiple cysticercus granuloma on radiological examination. 2 SE patients with meningo-encephalitis were suspected to be cases of Japanese encephalitis on the basis that they had myokimic SE and bilateral thalamic hyper intensities on MRI. 2 were found to have generalized white matter oedema on MRI. They were grouped as nonspecific meningo-encephalitis on the basis of this CSF abnormality. One SE patient was suspected to be a case of herpetic encephalitis due to a temporal lobe hyper intensity on MRI and a CSF abnormality (Table/Fig 3). CSF analysis was done in those who had the clinical signs of meningial irritation (n=7). One patient had findings which were suggestive of pyogenic meningitis, whereas the other had TB meningitis. 5 patients had mild lymphocytic pleocytosis with a mild increase in proteins, which as suggestive of aviral aetiology. Of the 50 patients with SE, 44 (88%) responded to the first-line drugs and 6 (12%) patients required second-line drugs. The variables which were studied to predict the response to the first-line-drugs, included the duration of SE and its aetiology [Table/Fig 4]. The non-responders in acute symptomatic SE were 15.4 % as compared to 8.4 % in other aetiologies (Table/Fig 4). The duration of SE and the delay in starting the treatment in all of the non-responders were more than 24 hours. 2 out of 3 deaths (6 %), were seen in the acute symptomatic group, one of them being a case of massive intra-cerebral bleeding and the other had Japanese encephalitis with refractory SE. The third death fell into the established epilepsy group whose SE was of 36 hours duration and he had primary epilepsy with intractable seizures, which caused acute renal failure and metabolic acidosis as terminal events.

Discussion

SE has been defined as a condition in which “a seizure either persists for a sufficient length of time or is repeated frequently enough, to produce a fixed and enduring epileptic condition” in the first international classification of epileptic seizures (4). Slight modifications were made in the subsequent definitions; however, the uncertainty about the duration of the seizures remained (5). Te recommendation of the Epilepsy Foundation of America’s Working Group on Status Epilepticus, in 1993, defined SE as (a), continuous seizure activity of more than 30 minutes, (b) two or more sequential seizures without the full recovery of consciousness (6). Experimental studies have shown that a neurological injury can occur much earlier than 30 minutes (7). Theodore et. al., (1994) reported that the mean seizure duration was 62 seconds. No seizure lasted for more than 2 minutes. The more prolonged seizures encourage the development of SE and a need for intravenous therapy (8). Based on the above study, it was proposed by Lowenstein et al., (1999) that the definition of SE should be: (a), a continuous seizure of more than 5 minutes duration or (b), 2 or more discrete seizures of 5 minutes duration between which there is an incomplete recovery of consciousness (2). The duration of SE and its aetiology are important predictors of its outcome (1),(8),(9). In the developed countries, pre-hospital treatment protocols were available for the paramedics to reduce the duration of SE and to improve its outcome (5). SE is a common medical emergency which accounts for 1% – 8% of all the hospital admissions for epilepsy (10). In the present study, SE was observed in 50 patients (1.43 %) out of 3500 patients, who visited the emergency department during October 2011 to March 2012. The mean age of the patients with SE was 29.94 ± 1.76 years (12–75 years), 22 % were in the younger age group (11-20 years) and 56 % fell into the young adult group (21-40 years). These findings were in agreement with those from another hospi3tal based series from the developing countries, wherein a higher proportion of the patients with SE were either children or young adults (20–40 years) (9),(11). However, in the developed countries, a bi-modal peak has been described with a high incidence in infants and in the elderly (12). This difference could either be due to various aetiological factors viz. post-anoxic or congenital lesions which are common in childhood or due to stroke or neurodegenerative disorders that are common in elderly patients. In the developed countries, socio-cultural factors viz. health insurance and the care of the elderly could be the important factors which account for this difference. In our study, the mean duration of SE before admission was 23.56 ± 3.16 hours, which ranged from 90 hours, which was comparable to that of a similar study which was done in south India (9). The most common aetiology which was found was acute symptomatic (52%), which was again comparable to that in another studies from India (9),(11). Of the acute symptomatic aetiology, cerebro-vascular disease was the predominant (40%-50 %) cause of SE in the developed countries (13),(14),(15),(16), whereas CNS infections accounted for 28–67 % of the aetiological spectrum in the developing countries (11),(17),(18). In the present study, 38% of the cases with SE were caused by infections, NCC being the commonest one (10/19; 52.6%). This was also in concordance with the finding of another study from Hyderabad, where NCC accounted for 42.5% of the SE cases (9). Meningo-encephalitis accounted for the SE in 5 patients (26.3%) in our study, which was slightly lower than that which was reported in a study from north India, where one third of the SE cases was caused due to meningo-encephalitis of which, nonspecific encephalitis was the commonest cause (19). However, the lowest incidence of meningo-encephalitis has been reported to be 15% (9). We found out that the incidence of SE due to stoke was 10% (5/50), out of which four patients had non haemorrhagic ischaemic stroke. A thrombo embolic infarct was seen in one patient with rheumatic heart disease (MS and MR) with atrial fibrillation. A similar incidence (12.8%) of SE due to stroke was also reported by Kalita et al., (11). It was also noted that 24% patients pertained to cryptogenic SE, which was comparable (19%) to the findings of a study from Hyderabad (9). 22% of the SE patients were established epileptics with a poor treatment compliance, either due to forgetfulness or ignorance. The increased cost of the AED treatment and the intermittent drug supply were also the factors which were responsible for the noncompliance. A drug default was noted in 7.9% and 20% patients in studies which were done at Lucknow and Hyderabad respectively (9),(11). A metabolic cause for SE was noted in 2 (4%) patients, which was lesser than that which was reported by Murthy et al., (11%) and Kalita et. al., (14.5%). This difference may be due to the small sample size of the present study. In the present study, one patient (2%) had remote symptomatic SE due to calcified lesions. Murthy et al., noted around 7% patients in this group; small calcified lesions being the most common finding (9). The CT/MRI scan was normal in 46% patients with SE, which was comparable to that in another Indian study (11). CT /MRI was abnormal in 23 out of 26 acute symptomatic SE patients (88.46%). In our study, 88% of the SE patients responded to the first-line drug treatment. The response rate was noted to be 50% and 88% in the studies from Lucknow and Hyderabad respectively (9), (11). The non-responders were more in the acute symptomatic SE (15.4%) group as compared to those in other aetiology groups (8.4%). CNS infection or haemorrhagic stroke was the common aetiology amongst the non-responders, which was comparable to that in other studies (11),(18),(19),(20). The duration of SE before the treatment in all the non-responders was more than 24 hours, which was similar to the observation which was made by Murthy et. al., (9). In large hospital-based studies, the mortality varies from 3%-50 %, depending on the study design and the case inclusion criteria (11),(19),(20). In our study, the mortality was lower (6%), probably due to the fact that the newer definition of SE was used for the case selection and management; unlike the other studies which were done with older definitions. 2 out of 3 deaths had occurred in the acute symptomatic group. One of these patients with refractory SE had suspected Japanese encephalitis. In a study which was done by Kalita et. al., on SE and CNS infections, it was observed that those with encephalitis had refractory seizures and poor outcomes (19). One of the patients in the established epilepsy group had refractory SE, who died due to acute renal failure and metabolic acidosis. Studies have shown that the terminal events could be hyperpyrexia, circulatory collapse, ATN and epileptic encephalopathy (21). In the present study, three out of 6 non-responders to the AED treatment, expired (50%). All of them had presented after 24 hours. Cherian et. al., commented that the longer the duration of SE, higher was the mortality and that a high degree of mortality was observed in the cases of refractory SE (12). The access to specialist care is a major limiting factor in the developing countries because of the poor health infrastructure and the connectivity, and the delays in transportation (8). In the present study, those who presented after 24 hours were amongst the non responder group and they had poor outcomes. It can be concluded that the duration of SE and acute symptomatic seizure are important predictors of a poor outcome. However, the present study had limitations due to its small sample size, the follow up of the patients and the non-availability of various serological tests to diagnose the type of meningo-encephalitis and the ring enhancing lesion. Further studies with large sample sizes and follow up of the patients are needed for the validation of these predictors and to look for long term outcomes.

References

1.
Rajshekher G. Recent trends in the management of status epilepticus. Indian J Crit Care Med. 2005;9(1):52-63.
2.
Lowenstein D, Bleck T, Mc Donald RL. It is time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120-22.
3.
Commission on the Epidemiology and the Prognosis of the ILAEGuidelines for epidemiological studies on epilepsy. Epilepsia. 1993;34(4):592-6.
4.
Commission on the Terminology of the International League of Epilepsy: A proposed international classification of epileptic seizures. Epilepsia. 1964;5:297-306.
5.
Smith BJ. The treatment of status epilepticus. Neurol Clin. 2001;19(2):347-69.
6.
Dodson WE, DeLorenzo RJ, Pedley TA, Shinnar S, Treiman DM, Wannamaker BB. The treatment of convulsive status epilepticus: Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA .1993;270(7):854 –9.
7.
Theodore WH, Porter RJ, Albert P, Kelly K, Bromfeild E, Devinsky O, et. al., The secondarily generalized tonic clonic seizures: A videotape analysis. Neurology .1994;44(8):1403-7.
8.
Tatum Iv WO, French JA, Benbadis SR, Kaplan PW. The aetiology and the diagnosis of status epilepticus. Epilepsy Behav. 2001;2(4):311-17.
9.
Murthy JM, Jayalaxmi SS, Kannikannan MA. Convulsive status epilepticus: the clinical profile in a developing country. Epilepsia. 2007;48(12):2217–23.
10.
Misra S, Singh NN. The management of status epilepticus. J Indian Med Assoc. 2002;100 (5):299-303.
11.
Kalita J, Nair PP, Misra UK. A clinical, radiological and outcome study on status epilepticus from India. J Neurol. 2010;257(2):224-9.
12.
Cherian A, Thomas SV. Status epilepticus. Ann Indian Acad Neurol. 2009;12(3):140-53.
13.
Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980;69(5):657-66.
14.
Fountain NB. Status epilepticus: risk factors and complications. Epilepsia. 2000; 41suppl 2:S23-30.
15.
Vignatelli L, Tonon C, D’Alessandro R. the Bologna Group for the Study of Status Epilepticus. The incidence and the short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia. 2003;44(7):964-8.
16.
Garzon E, Fernandes RM, Sakamoto AC. Analysis of the clinical characteristics and the risk factors for mortality in human status epilepticus. Seizure .2003;12(6):337-45.
17.
Murthy JM, Yangala R. Acute symptomatic seizures - incidence and aetiological spectrum: a hospital-based study from south India. Seizure. 1999;8(3) :162-5.
18.
Kwong KL, Lee SL, Yung A, Wong VC. Status epilepticus in 37 Chinese children: aetiology and outcome. J Paediatr Child Health. 1995;31(5):395-8.
19.
Misra UK, Kalita J, Nair PP. Status epilepticus in central nervous system infections: an experience from a developing country. Am J Med. 2008;121(7):618-23.
20.
Lowenstein DH, Alldredge BK .Status epilepticus at an urban hospital in the 1980s. Neurology .1993;43(3pt1):483-6.
21.
Hauser WA. Status epilepticus: epidemiological considerations.Neurology. 1990;40(5 suppl 2 ):9-13.

DOI and Others

ID: JCDR/2012/4497:2432

Date of Submission: May 07, 2012
Date of Peer Review: Jun 04, 2012
Date of Acceptance: Jul 04, 2012
Date of Publishing: Sep 30, 2012

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com